Valcyte and Oxycontin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Valcyte (valganciclovir hydrochloride) and Oxycontin (oxycodone hydrochloride). Common drug interactions include lymphopenia among females and hypophagia among males.

The phase IV clinical study analyzes what interactions people have when they take Valcyte and Oxycontin. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Valcyte?

Valcyte has active ingredients of valganciclovir hydrochloride. It is often used in cmv - immunocompromised host. eHealthMe is studying from 6,409 Valcyte users. Check the latest studies of Valcyte.

What is Oxycontin?

Oxycontin has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 212,533 Oxycontin users. Check the latest studies of Oxycontin.



On Jul, 06, 2026

18 people who take Valcyte and Oxycontin together, and have interactions are studied.

Valcyte and Oxycontin drug interactions.

What are the common drug interactions of Valcyte and Oxycontin, by gender? *:

female:

  1. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  4. Monocytosis (an increase in the number of monocytes circulating in the blood)
  5. Mucosal inflammation (infection of mucous membrane)
  6. Nail disorder (disease of nail)
  7. Neutrophilia
  8. Oedema peripheral (superficial swelling)
  9. Platelet count decreased
  10. Pre-eclampsia (high blood pressure and significant amounts of protein in the urine of a pregnant woman)

male:

  1. Hypophagia (reduced food intake)
  2. Dehydration (dryness resulting from the removal of water)
  3. Hypoxia (low oxygen in tissues)
  4. Leukopenia (less number of white blood cells in blood)
  5. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  6. Weight bearing difficulty (difficulty due to weight of thigh fat deposition)
  7. Abdominal pain
  8. Asthenia (weakness)
  9. Chronic kidney disease
  10. Haemoglobin decreased

What are the common drug interactions of Valcyte and Oxycontin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anaemia (lack of blood)
  2. Hip arthroplasty
  3. Hyperkalaemia (damage to or disease of the kidney)
  4. Hypoxia (low oxygen in tissues)
  5. Leukopenia (less number of white blood cells in blood)
  6. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  7. Weight bearing difficulty (difficulty due to weight of thigh fat deposition)

40-49:

  1. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  2. Platelet count decreased
  3. Renal failure (kidney dysfunction)
  4. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  5. White blood cell count decreased
  6. Blood creatinine increased
  7. Body temperature increased
  8. Chronic kidney disease
  9. Decreased appetite
  10. Drug toxicity

50-59:

  1. Nausea (feeling of having an urge to vomit)
  2. Platelet count decreased
  3. Pyrexia (fever)
  4. Abdominal hernia
  5. Blood creatinine increased
  6. Dysuria (painful or difficult urination)
  7. Fluid retention (an abnormal accumulation of fluid in the blood)
  8. Haemoglobin decreased
  9. Hepatic artery thrombosis (formation of a blood clot inside a hepatic artery)
  10. Intra-abdominal haemorrhage (intra-abdominal bleeding)

60+:

  1. Renal failure (kidney dysfunction)
  2. Chronic kidney disease
  3. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

What are the existing conditions these people have? *

  1. Depression: 4 people, 22.22%
  2. High Blood Cholesterol: 4 people, 22.22%
  3. High Blood Pressure: 4 people, 22.22%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.11%
  5. Cardiac Disorder: 2 people, 11.11%
  6. Fever: 2 people, 11.11%
  7. Indigestion: 2 people, 11.11%
  8. Immunodeficiency Disorders: 2 people, 11.11%
  9. Bone Disorder: 2 people, 11.11%
  10. Blood Glucose Abnormal: 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Valcyte and Oxycontin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Valcyte and Oxycontin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Valcyte:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Oxycontin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valcyte and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxycontin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on valganciclovir hydrochloride and oxycodone hydrochloride (the active ingredients of Valcyte and Oxycontin, respectively), and Valcyte and Oxycontin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: